Tirzepatide Superior to Semaglutide in Head-to-Head Type 2 Diabetes Study By Diana Ernst, RPh Publish Date March 4, 2021
Pafolacianine Sodium Gets Priority Review for Ovarian Cancer Detection During Surgery By Brian Park, PharmD Publish Date March 4, 2021
Baricitinib Improves Hair Regrowth in Alopecia Areata Trial By Lea Eslava-Kim, PharmD Publish Date March 4, 2021
Tesomet Granted Orphan Drug Status for Prader-Willi Syndrome By Brian Park, PharmD Publish Date March 3, 2021
Novel Therapy for Diffuse Intrinsic Pontine Glioma Fast Tracked By Diana Ernst, RPh Publish Date March 3, 2021
Cavrotolimod Designated Orphan Drug for Merkel Cell Carcinoma By Diana Ernst, RPh Publish Date March 3, 2021
FDA to Review Efgartigimod for Generalized Myasthenia Gravis By Brian Park, PharmD Publish Date March 2, 2021
Varenicline Nasal Spray Under Review for Dry Eye Disease By Brian Park, PharmD Publish Date March 2, 2021
Gefapixant Under Review for Refractory Chronic Cough By Brian Park, PharmD Publish Date March 1, 2021
Cabozantinib Gets Breakthrough Tx Status for Differentiated Thyroid Cancer By Brian Park, PharmD Publish Date February 26, 2021
ViiV Seeks Approval for Cabenuva Dosed Every 2 Months for HIV By Brian Park, PharmD Publish Date February 25, 2021
Moderna Outlines Strategy to Address SARS-CoV-2 Variants; Ships Variant Booster to NIH for Testing By Diana Ernst, RPh Publish Date February 25, 2021
Tipifarnib Gets Breakthrough Tx Designation for Head and Neck Cancer By Brian Park, PharmD Publish Date February 24, 2021
Tick-Borne Encephalitis Vaccine Gets Priority Review By Brian Park, PharmD Publish Date February 24, 2021
Ruxolitinib Gets Priority Review for Chronic Graft-vs-Host Disease By Brian Park, PharmD Publish Date February 23, 2021
Amgen Looks to Expand Apremilast Plaque Psoriasis Indication By Brian Park, PharmD Publish Date February 23, 2021
Upadacitinib Meets End Points in Ulcerative Colitis Trial By Brian Park, PharmD Publish Date February 23, 2021
Lumateperone sNDAs Submitted for Bipolar Depression Indication By Brian Park, PharmD Publish Date February 22, 2021
Ruxolitinib Cream Under Review for Atopic Dermatitis By Brian Park, PharmD Publish Date February 19, 2021
